Journal
VIRUS RESEARCH
Volume 317, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.virusres.2022.198815
Keywords
Influenza A virus; Monoclonal antibody; Antigenic site; Neutralization; Epitope
Categories
Funding
- National Science and Technology Major Project for the Control and Prevention of Major Infec-tious Diseases in China [2020ZX10001016-004-002, 2018ZX10711001, 2018ZX10102001]
- Zhejiang Provincial Natural Science Foundation of China [LY19H260006]
- Independent Task of State Key Laboratory for Diagnosis and Treatment of Infectious Diseases [2022ZZ02]
Ask authors/readers for more resources
This study generated a panel of neutralizing monoclonal antibodies against influenza A virus (H3N2) and identified relevant epitopes that influence antigenicity. The epitopes were mainly in antigenic site A, B, and C, with site B being the most immunodominant. Amino acid substitutions at site B resulted in decreased antibody capability for blocking receptor binding. The study also discovered a novel substitution at site C, which showed neutralizing activity against multiple H3N2 strains, suggesting a potential epitope for inducing broad neutralizing antibody responses.
Seasonal influenza viruses are highly contagious, leading to 290,000-650,000 mortalities every year globally. Among the influenza viruses, influenza A virus (H3N2) has attracted much attention due to its high frequency of antigenic variations, resulting in poor protection by vaccination. We generated a panel of murine neutralizing monoclonal antibodies (mAbs) against A/Texas/50/2012 (H3N2) and identified the relevant epitopes that potentially influence the antigenicity by selecting mAb-resistant mutants. The epitopes were mainly in antigenic site A (1/9, 11.1%), B (6/9, 66.7%), and C (1/9, 11.1%), which is consistent with recent reports on the immunodominance of antigenic site B. The amino acid substitutions at positions 156, 157, 159, 160, and 189 at antigenic site B resulted in decreased mAb capability for blocking receptor binding. In addition, the neutralizing spectra of three mAbs (1F8, 1G9 and 1H5) were different, suggesting that their epitopes may be different but partially overlapping, and it required further study. Further, the mAb 3F9 selected a new substitution, D53G/N, at antigenic site C and showed in vitro neutralizing activity against A/Victoria/361/2011 (H3N2), A/Texas/50/ 2012 (H3N2), and A/Hong Kong/2671/2019 (H3N2), suggesting a potential epitope on H3 hemagglutinin for inducing broad neutralizing antibody responses. Continuous research and regular monitoring of novel epitopes are of great importance for improving vaccine strain selection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available